Viloxazine Medication Guide

Non-Stimulant (SNRI)

Brand names: Qelbree

Source: U.S. FDA (openFDA) · data synced October 16, 2026

Conditions This Medication May Treat

Based on Bridgeway's clinical use. See the FDA "Uses" section below for approved indications.

ADHD (Attention-Deficit/Hyperactivity Disorder)

Most-Reported Adverse Events (FAERS)

Of 1,266 adverse-event reports mentioning Viloxazine submitted to the FDA, the most frequently reported reactions are:

  • Headache — 141 reports
  • Vomiting — 127 reports
  • Nausea — 122 reports
  • Migraine — 121 reports
  • Insomnia — 105 reports
  • Fatigue — 103 reports
  • Somnolence — 85 reports
  • Drug Ineffective — 81 reports
  • Suicidal Ideation — 81 reports
  • Anxiety — 54 reports

Source: FDA Adverse Event Reporting System (FAERS). These are voluntary, unverified reports from patients and providers worldwide — they do not mean the medication caused the reaction, and report counts reflect how widely a drug is used as much as its safety profile.

Medication management, integrated with care

At Bridgeway, medication is never a standalone solution. Our Utah providers coordinate medication management with ABA and mental health therapy so your family gets one connected plan.

Request an Appointment Call (801) 255-5131

Utah Locations

Bridgeway offers in-home, telehealth, and clinic-based care across Utah. Medication management is coordinated with our therapy teams at every center.

Brigham City Silvercreek Center Crossroads Center Redwood Center Lehi Richfield Blackrock Center St. George

Not medical advice. This page summarizes publicly available FDA drug labeling alongside general guidance from Bridgeway Integrated Healthcare Services. It is for educational purposes only and is not a substitute for advice from your prescriber or pharmacist. Never start, stop, or change a medication without talking to your healthcare provider. In an emergency, call 911.